Company / Working Capital
Disc Medicine, Inc. Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$767.3M
FY2025
5-year range
$77.1M / $767.3M
FY2021-FY2025
Trend
+63.1%
vs FY2024
Sector context
#55 of 213
Health Care
What the data says
At $767M, Disc Medicine, Inc.'s working capital ranks #55 of 213 in the Health Care sector. Working Capital has increased for 5 consecutive years, from -$20M in FY2020 to $767M in FY2025.
Based on SEC 10-K filings.
$767M in FY2025 with a 3-year CAGR of +63.4%.
Improved from $344M to $767M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +63.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#55 of 213 in Health CareTop 26% of 213This company $767.3M Sector average $934.6M
▼
-17.9% below sector average
Key checks
Key Insights
- Disc Medicine, Inc.'s working capital has grown for 5 consecutive years.
- 3-year CAGR of +63.4%, indicating consistent growth.
- In FY2025, working capital increased 63.1% year-over-year.
- Ranks #55 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $767.3M | +63.1% |
| FY2024 | $470.3M | +36.6% |
| FY2023 | $344.2M | +95.7% |
| FY2022 | $175.9M | +128.3% |
| FY2021 | $77.1M | +489.0% |
| FY2020 | -$19.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026